News and Updates
Remain updated with the recent developments and organization notifications.
Latest News & Research
Global Research Breakthroughs
Scientific Insights & Research Hub
The research work to be done on Lysosomal Storage Disorders or LSDs is one of the most leading and prominent studies in the field of modern medicine. There are revolutionary discoveries which include editing of genetics, engineering of enzymes and periodic substrate reduction therapies. We at Taraasha Foundation believe that strong information is the major strength for the families and patient advocacy groups.
Global Equity in Healthcare Access
Modern updates for worldwide health organizations such as the WHO lay stress upon certain relevant factors. Developed treatments like the CRISPR are in progress but medical setup for initial detection of the disease in India is still in requirement of major betterment. Grassroots movements and policy changes are monitored by us. These impact the lives of the children who have had metabolic diseases, which makes sure that our organization stays at the top.
The DCGI in India, the US FDA, and the EMA in Europe are significant global institutions which provide periodic validations for us to track at Taraasha Foundation. The parents and guardians need to understand the basic science of the lysosomal workings and cellular waste control. It would enable them to obtain effective medical care for their children in the long run by making wise and informed decisions.
Our news feed is a major informative source for all the relevant details pertaining to metabolic disorders in India. Be it a new phase III trial result for Pompe disease or a community awareness event, we remain focused on recording the global march toward a remedy for all kinds of LSDs and hereditary diseases.
Staying Informed as Empowerment
Every patient story that we bring forth is chosen with care to spread awareness, encourage and implement actions for the people of the lesser- known disease homes. Once the gulf between the top -notch research work and local actions is bridged, families are encouraged by us to spread awareness in their area and beyond.
We encourage you to bookmark this page and check back weekly as we aggregate new research breakthroughs and local impact stories from across the globe.
Gene Therapy Advances
2024 has seen pivotal strides in Gene Therapy for **Fabry Disease** and **Metachromatic Leukodystrophy (MLD)**. New one-time infusion treatments are showing potential for durable, multi-organ clinical benefits.
Source: Sangamo / NIHNext-Gen ERT
Enzyme Replacement Therapy (ERT) remains a cornerstone. Newer formulations are focusing on better blood-brain barrier penetration availability to treat neurological symptoms effectively.
Source: Grand View ResearchGlobal Collaboration
International consortiums like the **Lysosomal Diseases Gordon Research Conference 2025** are fostering crucial dialogue on lysosome biology, neurodegeneration, and immunity.
Source: Gordon Research Conference